Jwa-Kyung Kim

Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease

Jwa-Kyung Kim, Sun Ryoung Choi, Myung-Jin Choi et al. · Clinical Nutrition · 2013 · 281 citations

Urology, Elderly Patients, Geriatrics +7

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis

Jwa-Kyung Kim, Sung Gyun Kim, Jieun Oh et al. · The Korean Journal of Internal Medicine · 2017 · 134 citations · Full text

Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients

Young Rim Song, Jwa-Kyung Kim, Hyung‐Seok Lee et al. · BMC Nephrology · 2020 · 67 citations · Full text